ROLE SUMMARY

Since PAXLOVID’s emergency use authorization on 12/22/21, PAXLOVID has treated approximately 24M US patients at high-risk from progression to severe COVID-19, which can lead to hospitalization and/or death.  Now FDA approved and commercialized in the U.S., this novel protease inhibitor remains the gold standard in COVID-19 treatment.  Today there is an opportunity to increase treatment rates for eligible patients and bolster PAXLOVID’s leadership position in the marketplace via new clinical data, real-world data, and label indications.  A new indirect competitor to PAXLOVID is expected in the COVID-19 Oral Antiviral market in 2026, and Pfizer must continue to demonstrate PAXLOVID’s benefits to patients.  Lastly, Pfizer has a nextgen COVID-19 antiviral molecule in Phase3 clinical trials, and pending clinical data, could be an important piece to maintain long-term leadership in this space.

The US Antiviral Market Shaping Director will be a critical contributor to the Antiviral team and will report to the Antiviral Market Shaping Team Lead. This role is responsible for leading the COVID-19 ‘burden of disease’ (BoD) strategy for the Antiviral team, including messaging, piece development, and supporting pull-through across the team using compelling real-world data.  Additionally, this role will be responsible for monitoring the competitive environment and conceiving proactive and reactive strategies, tactics, and initiatives to retain Pfizer antiviral market leadership.   The role will require the ability to work collaboratively with cross-functional teams and requires the ability to identify and understand multiple forms of clinical data, and competitor trends in the market.  The role will develop insights and create a commercial narrative utilizing real-world data to activate HCPs and consumers.  The candidate will join a team that operates in an environment that embraces and encourages innovative ideas and creates a culture of collaboration and teamwork.

ROLE RESPONSIBILITIES

• Real World Data: Burden of Disease (BoD)
  • Own and manage the COVID-19 BoD strategy and coordinate pull-through for the US Antiviral team, staying connected to Global and other stakeholders
  • Monitor stream of external publications related to COVID-19 and PAXLOVID, and help identify items for potential use in US marketing
  • Develop compelling BoD messaging based on data points on COVID-19 patient impact (e.g., hospitalizations, deaths, ED visits) from CDC and other reporting data sources
  • Utilize market research and other testing to determine impact and viability of BoD messaging
  • Refresh existing COVID-19 BoD core pieces, where possible, with more recent publications and evidence
  • Identify publications that could allow for new health conditions to be added to overall COVID-19 BoD marketing
  • Close partnership with RC and BURC to develop novel and compliant messaging approaches
  • Develop, review, approve, and launch core marketing pieces
  • Partner with the US HCP, Consumer, and Access subteams to support integration across marketing materials and tactics

• Antiviral Competitive Intelligence and Strategy
  • Lead US competitive intelligence for our COVID-19 Antiviral portfolio, partnering cross-functionally and with Global
  • Responsible for gathering intelligence for existing and potential future competitors to our antivirals
  • Manage ongoing communication platform to align US colleagues and leadership regarding actual and future events in this space
  • Using knowledge and tracking of competitors, conceive proactive and reactive strategies, tactics, and initiatives to retain Pfizer antiviral market leadership and competitive advantage, and support pull-through with US HCP, Consumer, and Access subteams

• PAXLOVID Label Update Coordination & Lifecycle
  • Work with cross-functional team to identify and monitor expected label updates to PAXLOVID
  • Coordinate label update timelines with US brand team
  • Support efficient update plan to marketing material for label changes, meeting compliance requirements while avoiding unnecessary effort and spend

• Ibuzatrelvir Market Shaping
  • Ibuzatrelvir is Pfizer’s next generation COVID-19 Antiviral in Phase 3 clinical trials, potentially launching in the US in 2028
  • Pending clinical trial progress, in 2H-2026 this role likely would begin supporting and pulling-through pre-launch market-shaping activities as we move closer to this future launch

BASIC QUALIFICATIONS

• Bachelor's degree required
• 8+ years of pharmaceutical industry experience in consulting, sales, marketing, operations, or analytical roles
• Recent pharmaceutical marketing experience, and specifically strong experience of Pfizer’s marketing processes and systems, including agency oversight and the RC forum
• Strong analytical and problem-solving skills with demonstrated initiative, strategic thinking, and creativity
• Experience successfully converting market and stakeholder insights into actionable strategies and tactics
• Demonstrated ability to effectively lead and navigate within a complex organizational matrix achieving results through others across functions, geographies, and a variety of personality styles
• A commitment to excellence – both in the results achieved and in how they are achieved

PREFERRED QUALIFICATIONS

• Experience successfully engaging and partnering with field force colleagues and leadership
• US marketing experience

 
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

LAST DAY TO APPLY: 09/18/2025

The annual base salary for this position ranges from $169,700.00 to $282,900.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 20.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.

Relocation assistance may be available based on business needs and/or eligibility.

Marketing and Market Research